Meth costs rising
This article was originally published in The Tan Sheet
Executive Summary
Meth abuse caused facility costs to increase at 56% of hospitals who responded to a recent survey, the National Association of Counties announced Jan. 18. "The Effect of Meth on Hospital Emergency Rooms" was commissioned by the association in late 2005. The survey also finds that 47% of emergency rooms report meth as the top illicit drug involved in presentation at their hospitals, and 73% of hospitals say that meth-related ER presentations have increased over the last five years. Also, 83% of respondents said that patients presenting with a meth-related emergency are "often uninsured." Washington, D.C.-based Research, Inc. conducted the telephone surveys of 200 ERs in 48 states...
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.